Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Professor Lip said: “A decade ago the ESC conducted a registry on AF management as part of the Euro Heart Survey. Since then new treatments have become available and the ESC has published new guidelines on the management of AF.1,2 The time was right for a new registry to assess adherence to guidelines and how management has changed over time.”
Professor Lip said: “The proportion of patients with AF who receive oral anticoagulation hasn’t increased in the last 10 years despite the introduction of new anticoagulants. The current focus is the initial identification of ‘truly low risk’ patients with AF who do not need any antithrombotic therapy; subsequent to this step, patients with AF and one or more stroke risk factors can be offered effective stroke prevention, which is oral anticoagulation.”
Professor Lip said: “Asymptomatic AF is common and it’s often not picked up until something bad happens. In many cases, asymptomatic AF is first diagnosed when patients present with a complication, for example stroke or heart failure.”
Professor Lip concluded: “Patients with asymptomatic AF need to be identified earlier so they can be treated to avoid complications such as heart failure and stroke. And doctors should be encouraged to use oral anticoagulation in patients with AF to avoid needless occurrences of stroke.”
© 2017 European Society of Cardiology. All rights reserved